Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C1-inhibitor and transplantation.

Michael Kirschfink1

  • 1Institute of Immunology, University of Heidelberg, Germany. michael.kirschfink@urz.uni-heidelberg.de

Immunobiology
|October 25, 2002
PubMed
Summary

Complement activation contributes to transplant rejection and injury. C1-inhibitor, a complement regulator, shows promise in protecting organs from inflammatory damage in both animal models and clinical allotransplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiling of proteases involved in SARS-CoV-2 pathogenesis in human saliva: Influence of age and gender.

Journal, genetic engineering & biotechnology·2025
Same author

Radiotherapy Upregulates the Expression of Membrane-Bound Negative Complement Regulator Proteins on Tumor Cells and Limits Complement-Mediated Tumor Cell Lysis.

Cancers·2025
Same author

External quality assurance program for diagnostic complement laboratories: evaluation of the results of the past seven years.

Frontiers in immunology·2024
Same author

Editorial: Contemporary challenges in immunologic testing in clinical and research laboratories.

Frontiers in immunology·2023
Same author

Neutrophils activated by membrane attack complexes increase the permeability of melanoma blood vessels.

Proceedings of the National Academy of Sciences of the United States of America·2022
Same author

Expanding Horizons in Complement Analysis and Quality Control.

Frontiers in immunology·2021

Area of Science:

  • Immunology
  • Transplantation Biology

Background:

  • Excessive activation of protein cascade systems, particularly complement, is linked to post-transplantation inflammatory disorders.
  • Complement significantly contributes to ischemia/reperfusion injury and allograft rejection, especially in hyperacute and acute transplant rejection.

Purpose of the Study:

  • To review the impact of C1-inhibitor treatment on transplantation-associated inflammatory disorders.
  • To highlight the role of complement inhibition in protecting grafted organs.

Main Methods:

  • Review of studies using animal models of allo- and xenotransplantation.
  • Analysis of clinical results from successful allotransplantation.

Main Results:

  • C1-inhibitor, a regulator of kinin-generating cascades, is often reduced in patients with severe inflammatory disorders.
  • Evidence suggests C1-inhibitor effectively protects grafted organs against inflammatory injury in animal models and clinical settings.
  • Complement inhibition by C1-inhibitor may overcome hyperacute graft rejection in xenotransplantation.

Conclusions:

  • Therapeutic substitution with complement regulators like C1-inhibitor is a viable approach to mitigate inflammatory reactions in transplanted organs.
  • C1-inhibitor demonstrates potential as a protective agent against inflammatory tissue injury in transplantation.

Related Experiment Videos